Elizabeth Bayliss
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deprescriptions | 15 | 2025 | 34 | 7.780 |
Why?
| Chronic Disease | 32 | 2024 | 1727 | 4.320 |
Why?
| Dementia | 11 | 2025 | 230 | 2.970 |
Why?
| Cognitive Dysfunction | 7 | 2024 | 346 | 2.950 |
Why?
| Multiple Chronic Conditions | 12 | 2024 | 29 | 2.930 |
Why?
| Patient Portals | 5 | 2024 | 42 | 2.610 |
Why?
| Primary Health Care | 23 | 2025 | 1677 | 2.470 |
Why?
| Comorbidity | 23 | 2018 | 1555 | 2.320 |
Why?
| Patient-Centered Care | 8 | 2021 | 506 | 1.960 |
Why?
| Patient Care Team | 9 | 2019 | 612 | 1.830 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 4 | 2024 | 260 | 1.720 |
Why?
| Aged | 69 | 2025 | 22282 | 1.570 |
Why?
| Electronic Health Records | 8 | 2025 | 979 | 1.540 |
Why?
| Delivery of Health Care, Integrated | 6 | 2021 | 249 | 1.390 |
Why?
| Potentially Inappropriate Medication List | 4 | 2024 | 16 | 1.390 |
Why?
| Health Status | 8 | 2019 | 756 | 1.370 |
Why?
| Aged, 80 and over | 33 | 2025 | 7128 | 1.370 |
Why?
| Physicians, Primary Care | 7 | 2019 | 233 | 1.330 |
Why?
| Quality of Life | 16 | 2022 | 2735 | 1.290 |
Why?
| Safety-net Providers | 3 | 2021 | 109 | 1.210 |
Why?
| Depressive Disorder | 4 | 2012 | 363 | 1.150 |
Why?
| Delivery of Health Care | 8 | 2021 | 906 | 1.150 |
Why?
| Inappropriate Prescribing | 2 | 2024 | 54 | 1.100 |
Why?
| Continuity of Patient Care | 4 | 2019 | 280 | 1.100 |
Why?
| Communication | 8 | 2025 | 844 | 1.040 |
Why?
| Quality of Health Care | 4 | 2021 | 611 | 1.040 |
Why?
| Self Care | 6 | 2012 | 370 | 1.020 |
Why?
| Female | 83 | 2025 | 68842 | 1.010 |
Why?
| Male | 81 | 2025 | 63748 | 1.000 |
Why?
| Humans | 117 | 2025 | 130305 | 0.970 |
Why?
| Mental Disorders | 6 | 2020 | 1032 | 0.910 |
Why?
| Caregivers | 13 | 2025 | 826 | 0.910 |
Why?
| Chronic Pain | 2 | 2022 | 251 | 0.900 |
Why?
| Benzodiazepines | 1 | 2024 | 133 | 0.870 |
Why?
| Health Services | 2 | 2017 | 106 | 0.870 |
Why?
| Attitude of Health Personnel | 5 | 2017 | 1095 | 0.840 |
Why?
| Gastric Bypass | 2 | 2014 | 107 | 0.820 |
Why?
| Polypharmacy | 7 | 2024 | 83 | 0.780 |
Why?
| Health Status Indicators | 2 | 2014 | 168 | 0.780 |
Why?
| Retrospective Studies | 30 | 2024 | 14675 | 0.770 |
Why?
| Qualitative Research | 13 | 2025 | 1205 | 0.760 |
Why?
| Medication Adherence | 5 | 2022 | 577 | 0.750 |
Why?
| Cholinergic Antagonists | 2 | 2019 | 29 | 0.730 |
Why?
| United States | 31 | 2024 | 14110 | 0.730 |
Why?
| Food Supply | 1 | 2021 | 72 | 0.720 |
Why?
| Health Plan Implementation | 2 | 2019 | 137 | 0.700 |
Why?
| Colorado | 16 | 2025 | 4471 | 0.690 |
Why?
| Cohort Studies | 19 | 2025 | 5431 | 0.680 |
Why?
| Self Efficacy | 3 | 2019 | 377 | 0.670 |
Why?
| Patient Reported Outcome Measures | 4 | 2019 | 363 | 0.670 |
Why?
| Mental Health Services | 3 | 2019 | 406 | 0.650 |
Why?
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 986 | 0.650 |
Why?
| Advance Directives | 1 | 2020 | 78 | 0.650 |
Why?
| Hospitalization | 7 | 2024 | 2094 | 0.630 |
Why?
| Middle Aged | 42 | 2025 | 31322 | 0.630 |
Why?
| Medicare Part D | 2 | 2010 | 28 | 0.630 |
Why?
| Practice Guidelines as Topic | 3 | 2021 | 1537 | 0.610 |
Why?
| Telemedicine | 4 | 2024 | 791 | 0.610 |
Why?
| Documentation | 1 | 2020 | 184 | 0.600 |
Why?
| Delayed Diagnosis | 1 | 2018 | 81 | 0.600 |
Why?
| Health Services Needs and Demand | 3 | 2015 | 260 | 0.590 |
Why?
| Diabetic Neuropathies | 2 | 2016 | 90 | 0.580 |
Why?
| Hypolipidemic Agents | 3 | 2017 | 93 | 0.580 |
Why?
| Patient Acceptance of Health Care | 4 | 2021 | 771 | 0.550 |
Why?
| Specialization | 2 | 2017 | 147 | 0.550 |
Why?
| Time-to-Treatment | 1 | 2018 | 183 | 0.550 |
Why?
| Maryland | 4 | 2025 | 43 | 0.530 |
Why?
| Health Maintenance Organizations | 6 | 2012 | 99 | 0.530 |
Why?
| Healthcare Disparities | 2 | 2021 | 580 | 0.510 |
Why?
| Medically Uninsured | 1 | 2017 | 127 | 0.510 |
Why?
| Health Knowledge, Attitudes, Practice | 6 | 2021 | 1272 | 0.510 |
Why?
| Practice Patterns, Physicians' | 3 | 2017 | 1294 | 0.510 |
Why?
| Adult | 34 | 2024 | 35711 | 0.510 |
Why?
| Patient Satisfaction | 4 | 2019 | 647 | 0.510 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2023 | 2440 | 0.510 |
Why?
| Self Report | 6 | 2024 | 802 | 0.500 |
Why?
| Medicaid | 2 | 2022 | 448 | 0.500 |
Why?
| Patients | 2 | 2021 | 168 | 0.500 |
Why?
| Health Promotion | 1 | 2021 | 717 | 0.490 |
Why?
| Antihypertensive Agents | 5 | 2019 | 489 | 0.480 |
Why?
| Pain Management | 2 | 2015 | 322 | 0.480 |
Why?
| Sickness Impact Profile | 2 | 2005 | 55 | 0.480 |
Why?
| Bariatric Surgery | 2 | 2015 | 190 | 0.470 |
Why?
| Gastroplasty | 1 | 2014 | 29 | 0.470 |
Why?
| Hypoglycemic Agents | 5 | 2019 | 1218 | 0.460 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2015 | 101 | 0.460 |
Why?
| Surveys and Questionnaires | 17 | 2022 | 5400 | 0.450 |
Why?
| Diabetes Mellitus | 7 | 2017 | 1005 | 0.450 |
Why?
| Neuralgia | 1 | 2015 | 123 | 0.440 |
Why?
| Drug Utilization | 2 | 2012 | 170 | 0.440 |
Why?
| Hypertension | 7 | 2019 | 1245 | 0.440 |
Why?
| Focus Groups | 5 | 2020 | 447 | 0.430 |
Why?
| Health Services Accessibility | 3 | 2017 | 902 | 0.430 |
Why?
| Sleep Deprivation | 1 | 2015 | 171 | 0.420 |
Why?
| Postoperative Care | 1 | 2015 | 246 | 0.420 |
Why?
| Morbidity | 2 | 2012 | 302 | 0.420 |
Why?
| Laparoscopy | 2 | 2014 | 456 | 0.420 |
Why?
| Socioeconomic Factors | 7 | 2020 | 1200 | 0.420 |
Why?
| Comparative Effectiveness Research | 1 | 2014 | 152 | 0.410 |
Why?
| Colorectal Neoplasms | 3 | 2014 | 733 | 0.410 |
Why?
| Preoperative Care | 1 | 2015 | 343 | 0.400 |
Why?
| Morphine | 1 | 2013 | 128 | 0.400 |
Why?
| Cross-Sectional Studies | 14 | 2023 | 5083 | 0.390 |
Why?
| Osteoarthritis | 3 | 2008 | 180 | 0.380 |
Why?
| Antidepressive Agents, Second-Generation | 1 | 2012 | 44 | 0.380 |
Why?
| Cluster Analysis | 2 | 2020 | 485 | 0.370 |
Why?
| Referral and Consultation | 1 | 2017 | 736 | 0.370 |
Why?
| International Classification of Diseases | 1 | 2012 | 124 | 0.360 |
Why?
| Psychotherapy | 1 | 2012 | 162 | 0.360 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 423 | 0.360 |
Why?
| Severity of Illness Index | 3 | 2015 | 2785 | 0.350 |
Why?
| Antidepressive Agents | 1 | 2012 | 228 | 0.350 |
Why?
| Office Visits | 3 | 2018 | 85 | 0.350 |
Why?
| Obesity | 2 | 2014 | 2869 | 0.350 |
Why?
| Quality Improvement | 5 | 2020 | 1111 | 0.340 |
Why?
| Prostatic Neoplasms | 2 | 2014 | 1004 | 0.340 |
Why?
| Physician-Patient Relations | 6 | 2019 | 541 | 0.340 |
Why?
| Models, Statistical | 1 | 2014 | 630 | 0.340 |
Why?
| Risk Assessment | 8 | 2024 | 3310 | 0.330 |
Why?
| Patient Preference | 3 | 2022 | 183 | 0.330 |
Why?
| Perception | 3 | 2020 | 339 | 0.320 |
Why?
| Vaccination Refusal | 2 | 2021 | 69 | 0.320 |
Why?
| Multimorbidity | 2 | 2021 | 45 | 0.320 |
Why?
| Neoplasms | 3 | 2014 | 2467 | 0.320 |
Why?
| Research | 3 | 2018 | 415 | 0.320 |
Why?
| Patient Participation | 5 | 2022 | 406 | 0.320 |
Why?
| Stakeholder Participation | 2 | 2020 | 76 | 0.310 |
Why?
| Analgesics, Opioid | 2 | 2014 | 921 | 0.310 |
Why?
| Emergency Service, Hospital | 3 | 2015 | 1986 | 0.310 |
Why?
| Medicare | 6 | 2023 | 740 | 0.300 |
Why?
| Health Personnel | 3 | 2019 | 649 | 0.300 |
Why?
| Depressive Disorder, Major | 1 | 2012 | 350 | 0.290 |
Why?
| Delphi Technique | 4 | 2018 | 223 | 0.290 |
Why?
| Health Services for the Aged | 1 | 2008 | 72 | 0.290 |
Why?
| Geriatrics | 1 | 2008 | 80 | 0.280 |
Why?
| Disease Progression | 2 | 2015 | 2639 | 0.280 |
Why?
| Cost of Illness | 2 | 2008 | 292 | 0.280 |
Why?
| Glomerular Filtration Rate | 1 | 2011 | 691 | 0.270 |
Why?
| Kidney Diseases | 1 | 2011 | 377 | 0.270 |
Why?
| Breast Neoplasms | 1 | 2018 | 2139 | 0.260 |
Why?
| Psychometrics | 3 | 2018 | 688 | 0.260 |
Why?
| Accidental Falls | 2 | 2019 | 171 | 0.260 |
Why?
| Telephone | 2 | 2017 | 169 | 0.250 |
Why?
| Pain Measurement | 2 | 2018 | 491 | 0.230 |
Why?
| Disease Management | 4 | 2017 | 597 | 0.230 |
Why?
| Patient Compliance | 1 | 2008 | 565 | 0.230 |
Why?
| Nomograms | 2 | 2014 | 48 | 0.230 |
Why?
| Parents | 3 | 2021 | 1313 | 0.230 |
Why?
| Single-Payer System | 1 | 2003 | 2 | 0.220 |
Why?
| National Health Insurance, United States | 1 | 2003 | 5 | 0.220 |
Why?
| Cardiovascular Diseases | 2 | 2014 | 2028 | 0.220 |
Why?
| Pragmatic Clinical Trials as Topic | 2 | 2022 | 62 | 0.220 |
Why?
| Natural Language Processing | 1 | 2025 | 94 | 0.220 |
Why?
| Managed Care Programs | 2 | 2014 | 136 | 0.220 |
Why?
| Death | 2 | 2022 | 124 | 0.220 |
Why?
| Multivariate Analysis | 5 | 2013 | 1510 | 0.220 |
Why?
| Dyslipidemias | 3 | 2019 | 177 | 0.220 |
Why?
| Vaccination | 3 | 2021 | 1361 | 0.210 |
Why?
| Health Services Research | 3 | 2017 | 392 | 0.210 |
Why?
| Interdisciplinary Communication | 2 | 2014 | 189 | 0.200 |
Why?
| Health Care Reform | 1 | 2003 | 100 | 0.200 |
Why?
| Insurance Coverage | 2 | 2018 | 223 | 0.200 |
Why?
| Data Collection | 1 | 2005 | 654 | 0.200 |
Why?
| Attitude | 2 | 2021 | 248 | 0.200 |
Why?
| Prognosis | 4 | 2014 | 3830 | 0.200 |
Why?
| Substance Withdrawal Syndrome | 1 | 2024 | 173 | 0.200 |
Why?
| Pharmacists | 1 | 2025 | 263 | 0.190 |
Why?
| Asthma | 2 | 2016 | 2265 | 0.190 |
Why?
| Physicians | 2 | 2023 | 865 | 0.190 |
Why?
| Survival Rate | 3 | 2014 | 1904 | 0.190 |
Why?
| Interviews as Topic | 4 | 2024 | 705 | 0.180 |
Why?
| Proxy | 1 | 2021 | 26 | 0.180 |
Why?
| Information Storage and Retrieval | 1 | 2021 | 107 | 0.180 |
Why?
| Patient Care Management | 1 | 2020 | 57 | 0.170 |
Why?
| Longitudinal Studies | 4 | 2018 | 2691 | 0.170 |
Why?
| Age Factors | 6 | 2019 | 3153 | 0.170 |
Why?
| Clergy | 1 | 2020 | 12 | 0.170 |
Why?
| Pharmaceutical Preparations | 1 | 2022 | 172 | 0.170 |
Why?
| Fee-for-Service Plans | 2 | 2014 | 90 | 0.170 |
Why?
| Anti-Vaccination Movement | 1 | 2019 | 4 | 0.170 |
Why?
| Health Surveys | 3 | 2012 | 495 | 0.170 |
Why?
| Southwestern United States | 1 | 2019 | 91 | 0.160 |
Why?
| Urban Health Services | 1 | 2019 | 61 | 0.160 |
Why?
| Residence Characteristics | 1 | 2022 | 330 | 0.160 |
Why?
| Follow-Up Studies | 4 | 2017 | 4961 | 0.160 |
Why?
| Child, Preschool | 5 | 2021 | 10514 | 0.160 |
Why?
| Religion | 1 | 2019 | 70 | 0.160 |
Why?
| Interprofessional Relations | 2 | 2013 | 275 | 0.160 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 47 | 0.160 |
Why?
| Time Factors | 5 | 2018 | 6615 | 0.160 |
Why?
| Attitude to Health | 2 | 2015 | 428 | 0.150 |
Why?
| Comprehensive Health Care | 2 | 2017 | 21 | 0.150 |
Why?
| Contraindications, Drug | 1 | 2018 | 7 | 0.150 |
Why?
| Research Design | 2 | 2024 | 1052 | 0.150 |
Why?
| Radiotherapy, Adjuvant | 1 | 2018 | 213 | 0.150 |
Why?
| Medical Informatics | 1 | 2019 | 99 | 0.150 |
Why?
| Mastectomy | 1 | 2018 | 130 | 0.150 |
Why?
| Vaccines | 2 | 2020 | 404 | 0.140 |
Why?
| Models, Theoretical | 1 | 2021 | 553 | 0.140 |
Why?
| Chemotherapy, Adjuvant | 1 | 2018 | 383 | 0.140 |
Why?
| Prospective Studies | 5 | 2023 | 7131 | 0.140 |
Why?
| Young Adult | 6 | 2016 | 12404 | 0.140 |
Why?
| SEER Program | 2 | 2014 | 208 | 0.140 |
Why?
| Independent Living | 1 | 2018 | 98 | 0.140 |
Why?
| Case Management | 1 | 2017 | 64 | 0.130 |
Why?
| Logistic Models | 5 | 2013 | 1980 | 0.130 |
Why?
| General Practice | 1 | 2016 | 28 | 0.130 |
Why?
| Electronics | 1 | 2017 | 74 | 0.130 |
Why?
| Blood Pressure | 3 | 2019 | 1753 | 0.130 |
Why?
| Medication Therapy Management | 1 | 2017 | 71 | 0.130 |
Why?
| Schools | 1 | 2019 | 445 | 0.130 |
Why?
| Influenza Vaccines | 1 | 2021 | 546 | 0.130 |
Why?
| Adolescent | 6 | 2015 | 20374 | 0.130 |
Why?
| Patient Outcome Assessment | 1 | 2017 | 129 | 0.130 |
Why?
| Health Care Costs | 1 | 2019 | 407 | 0.120 |
Why?
| Validation Studies as Topic | 1 | 2015 | 22 | 0.120 |
Why?
| Body Mass Index | 2 | 2014 | 2268 | 0.120 |
Why?
| Risk Factors | 7 | 2024 | 9865 | 0.120 |
Why?
| Metformin | 1 | 2019 | 312 | 0.120 |
Why?
| Clinical Decision-Making | 1 | 2018 | 313 | 0.120 |
Why?
| Influenza, Human | 1 | 2021 | 606 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2018 | 1294 | 0.120 |
Why?
| Infant | 2 | 2021 | 9049 | 0.120 |
Why?
| Hyperlipidemias | 2 | 2012 | 126 | 0.120 |
Why?
| United States Agency for Healthcare Research and Quality | 1 | 2014 | 10 | 0.110 |
Why?
| Proportional Hazards Models | 2 | 2015 | 1235 | 0.110 |
Why?
| California | 3 | 2024 | 403 | 0.110 |
Why?
| Health Priorities | 1 | 2014 | 34 | 0.110 |
Why?
| Stress Disorders, Post-Traumatic | 1 | 2022 | 836 | 0.110 |
Why?
| Health Education | 1 | 2016 | 329 | 0.110 |
Why?
| Child | 5 | 2021 | 20961 | 0.110 |
Why?
| Activities of Daily Living | 2 | 2008 | 390 | 0.110 |
Why?
| Cooperative Behavior | 2 | 2014 | 431 | 0.110 |
Why?
| Age Distribution | 1 | 2014 | 379 | 0.100 |
Why?
| Decision Making | 1 | 2019 | 842 | 0.100 |
Why?
| Guideline Adherence | 1 | 2017 | 534 | 0.100 |
Why?
| Terminally Ill | 1 | 2013 | 35 | 0.100 |
Why?
| Lung Diseases, Obstructive | 1 | 2012 | 46 | 0.100 |
Why?
| Postoperative Period | 1 | 2013 | 325 | 0.100 |
Why?
| Information Dissemination | 1 | 2014 | 208 | 0.100 |
Why?
| Program Evaluation | 1 | 2017 | 878 | 0.100 |
Why?
| Postoperative Complications | 2 | 2014 | 2511 | 0.100 |
Why?
| Depression | 3 | 2018 | 1298 | 0.100 |
Why?
| Quality Assurance, Health Care | 1 | 2014 | 320 | 0.090 |
Why?
| Secondary Prevention | 1 | 2013 | 238 | 0.090 |
Why?
| Diabetes Complications | 1 | 2013 | 228 | 0.090 |
Why?
| Primary Prevention | 1 | 2013 | 193 | 0.090 |
Why?
| Obesity, Morbid | 1 | 2014 | 241 | 0.090 |
Why?
| Insulin | 2 | 2019 | 2322 | 0.090 |
Why?
| Anticholesteremic Agents | 1 | 2012 | 146 | 0.090 |
Why?
| Data Mining | 1 | 2011 | 110 | 0.090 |
Why?
| Pandemics | 3 | 2024 | 1538 | 0.080 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 235 | 0.080 |
Why?
| Weight Loss | 1 | 2015 | 728 | 0.080 |
Why?
| Evidence-Based Medicine | 1 | 2014 | 733 | 0.080 |
Why?
| Emigrants and Immigrants | 1 | 2012 | 121 | 0.080 |
Why?
| Databases, Factual | 2 | 2012 | 1300 | 0.080 |
Why?
| Reproducibility of Results | 3 | 2019 | 3069 | 0.080 |
Why?
| Prescription Fees | 1 | 2008 | 4 | 0.080 |
Why?
| Arthroplasty, Replacement, Knee | 1 | 2013 | 280 | 0.080 |
Why?
| Medical Records Systems, Computerized | 2 | 2007 | 92 | 0.080 |
Why?
| Poisson Distribution | 1 | 2008 | 76 | 0.080 |
Why?
| Self Disclosure | 1 | 2008 | 62 | 0.080 |
Why?
| Drug Utilization Review | 1 | 2008 | 58 | 0.080 |
Why?
| Eligibility Determination | 1 | 2008 | 64 | 0.070 |
Why?
| Autoimmune Diseases | 1 | 2012 | 426 | 0.070 |
Why?
| Pain | 1 | 2014 | 765 | 0.070 |
Why?
| Community Health Services | 1 | 2010 | 224 | 0.070 |
Why?
| Incidence | 2 | 2014 | 2657 | 0.070 |
Why?
| Treatment Outcome | 4 | 2016 | 10341 | 0.070 |
Why?
| Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| Biomedical Research | 1 | 2014 | 658 | 0.070 |
Why?
| Immunoglobulin G | 1 | 2012 | 845 | 0.070 |
Why?
| Treatment Refusal | 1 | 2007 | 88 | 0.070 |
Why?
| Sex Distribution | 1 | 2007 | 361 | 0.070 |
Why?
| Odds Ratio | 3 | 2014 | 1027 | 0.070 |
Why?
| Opioid-Related Disorders | 1 | 2014 | 506 | 0.060 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2023 | 3629 | 0.060 |
Why?
| Coronary Artery Disease | 1 | 2012 | 697 | 0.060 |
Why?
| Urban Population | 2 | 2012 | 439 | 0.060 |
Why?
| Mass Screening | 1 | 2013 | 1139 | 0.060 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1372 | 0.060 |
Why?
| Linear Models | 1 | 2007 | 826 | 0.060 |
Why?
| Chicago | 1 | 2004 | 52 | 0.060 |
Why?
| Los Angeles | 1 | 2004 | 63 | 0.060 |
Why?
| Contraceptives, Oral | 1 | 2024 | 39 | 0.060 |
Why?
| Boston | 1 | 2004 | 89 | 0.060 |
Why?
| Causality | 1 | 2024 | 116 | 0.060 |
Why?
| Self Concept | 1 | 2005 | 238 | 0.050 |
Why?
| Algorithms | 1 | 2011 | 1638 | 0.050 |
Why?
| Choice Behavior | 1 | 2005 | 161 | 0.050 |
Why?
| Goals | 1 | 2005 | 165 | 0.050 |
Why?
| Estrogen Replacement Therapy | 1 | 2024 | 142 | 0.050 |
Why?
| Social Support | 1 | 2007 | 586 | 0.050 |
Why?
| Medicine | 1 | 2004 | 119 | 0.050 |
Why?
| Regression Analysis | 1 | 2004 | 991 | 0.050 |
Why?
| Internet | 2 | 2019 | 618 | 0.050 |
Why?
| Self-Management | 1 | 2024 | 160 | 0.050 |
Why?
| Estrogens | 1 | 2024 | 355 | 0.050 |
Why?
| Insurance Claim Review | 1 | 2021 | 75 | 0.050 |
Why?
| Washington | 1 | 2021 | 149 | 0.050 |
Why?
| Housing | 1 | 2022 | 135 | 0.050 |
Why?
| Cholesterol, LDL | 2 | 2014 | 361 | 0.040 |
Why?
| Chi-Square Distribution | 2 | 2012 | 517 | 0.040 |
Why?
| Medical Records | 1 | 2021 | 171 | 0.040 |
Why?
| Resource Allocation | 1 | 2020 | 40 | 0.040 |
Why?
| Health Expenditures | 1 | 2022 | 191 | 0.040 |
Why?
| Assisted Living Facilities | 1 | 2020 | 10 | 0.040 |
Why?
| Health Care Rationing | 1 | 2020 | 61 | 0.040 |
Why?
| Minority Groups | 1 | 2022 | 242 | 0.040 |
Why?
| Pilot Projects | 1 | 2025 | 1565 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 123 | 0.040 |
Why?
| Health Behavior | 1 | 2005 | 735 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 2164 | 0.040 |
Why?
| Nursing Homes | 1 | 2020 | 155 | 0.040 |
Why?
| Mortality | 1 | 2020 | 310 | 0.040 |
Why?
| Appointments and Schedules | 1 | 2019 | 81 | 0.040 |
Why?
| Stress, Psychological | 1 | 2007 | 1058 | 0.040 |
Why?
| Social Determinants of Health | 1 | 2021 | 218 | 0.040 |
Why?
| Medicare Part C | 1 | 2019 | 42 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 793 | 0.040 |
Why?
| Factor Analysis, Statistical | 1 | 2018 | 285 | 0.040 |
Why?
| Intention | 1 | 2019 | 159 | 0.040 |
Why?
| Fatigue | 1 | 2018 | 322 | 0.030 |
Why?
| Drug Therapy, Combination | 1 | 2019 | 1028 | 0.030 |
Why?
| Guidelines as Topic | 1 | 2018 | 262 | 0.030 |
Why?
| Automation | 1 | 2016 | 83 | 0.030 |
Why?
| Drug Interactions | 1 | 2017 | 370 | 0.030 |
Why?
| Hospitals | 1 | 2020 | 641 | 0.030 |
Why?
| Prevalence | 1 | 2022 | 2576 | 0.030 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 251 | 0.030 |
Why?
| Consensus | 1 | 2018 | 652 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2017 | 621 | 0.030 |
Why?
| Analysis of Variance | 2 | 2007 | 1291 | 0.030 |
Why?
| Patient Access to Records | 1 | 2013 | 20 | 0.030 |
Why?
| ROC Curve | 1 | 2014 | 507 | 0.030 |
Why?
| Electronic Mail | 1 | 2013 | 61 | 0.030 |
Why?
| Remote Consultation | 1 | 2013 | 46 | 0.020 |
Why?
| Turkey | 1 | 2012 | 18 | 0.020 |
Why?
| Etanercept | 1 | 2012 | 58 | 0.020 |
Why?
| Forecasting | 1 | 2014 | 364 | 0.020 |
Why?
| Mental Health | 1 | 2018 | 688 | 0.020 |
Why?
| London | 1 | 2012 | 46 | 0.020 |
Why?
| Infliximab | 1 | 2012 | 102 | 0.020 |
Why?
| Cross-Cultural Comparison | 1 | 2012 | 80 | 0.020 |
Why?
| Needs Assessment | 1 | 2014 | 363 | 0.020 |
Why?
| Anxiety | 1 | 2018 | 957 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2012 | 163 | 0.020 |
Why?
| Biomarkers | 2 | 2013 | 3923 | 0.020 |
Why?
| United Kingdom | 1 | 2012 | 266 | 0.020 |
Why?
| Reoperation | 1 | 2013 | 558 | 0.020 |
Why?
| Immunologic Factors | 1 | 2012 | 232 | 0.020 |
Why?
| Antirheumatic Agents | 1 | 2012 | 283 | 0.020 |
Why?
| Risk | 1 | 2012 | 873 | 0.020 |
Why?
| Models, Organizational | 1 | 2010 | 149 | 0.020 |
Why?
| Sex Characteristics | 1 | 2014 | 728 | 0.020 |
Why?
| Aging | 1 | 2018 | 1785 | 0.020 |
Why?
| Empathy | 1 | 2010 | 173 | 0.020 |
Why?
| Patient Readmission | 1 | 2013 | 680 | 0.020 |
Why?
| Holistic Health | 1 | 2007 | 15 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1210 | 0.020 |
Why?
| Sex Factors | 1 | 2012 | 1965 | 0.020 |
Why?
| Learning | 1 | 2010 | 391 | 0.020 |
Why?
| CD-ROM | 1 | 2005 | 6 | 0.020 |
Why?
| Veterans | 1 | 2017 | 1428 | 0.020 |
Why?
| Diet, Fat-Restricted | 1 | 2005 | 79 | 0.010 |
Why?
| Computer-Assisted Instruction | 1 | 2005 | 60 | 0.010 |
Why?
| Nonlinear Dynamics | 1 | 2005 | 88 | 0.010 |
Why?
| Registries | 1 | 2012 | 1934 | 0.010 |
Why?
| Fruit | 1 | 2005 | 131 | 0.010 |
Why?
| Patient Care Planning | 1 | 2005 | 152 | 0.010 |
Why?
| Vegetables | 1 | 2005 | 147 | 0.010 |
Why?
| Patient Education as Topic | 1 | 2005 | 739 | 0.010 |
Why?
| Exercise | 1 | 2005 | 1941 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|